semaglutide gout GLP-1 Medications and Risk: What You Need to Know Gout: an Overview

Sodium-glucose co-transporter 2 inhibitors (SGLT2i) have emerged as important agents for the treatment of type 2 diabetes mellitus (T2DM)

Background Psoriasis is a chronic inflammatory skin disease driven by immune dysregulation and often exacerbated by metabolic comorbidities

Yes, many type 2 diabetics on Ozempic (semaglutide) can successfully discontinue insulin, particularly those on basal insulin alone or basal-bolus regimens, ...

The largest study to date has reported that despite the explosion in demand for GLP-1s, 58% of patients discontinue use before reaching a clinically meaningful health benefit, according to research by the Blue Cross Blue Shield Association (BCBSA) and conducted by Blue Health Intelligence (BHI).This large-scale study of commercial health plan data examined national pharmacy and medical claims data for treatment persistence patterns in the use of GLP-1s for weight management by members of Blue Cr

Follow me (Daniel Carlat, for real-world, clinician-led updates